FDA is departing from long-standing procedures to deal with public health crises, and this may foreshadow problems for COVID-19 vaccines
- Written by Ana Santos Rutschman, Assistant Professor of Law, Saint Louis University
FDA Commissioner Stephen Hahn, right, and President Trump at a Coronavirus Task Force meeting March 19, 2020.Chip Somodevilla/Getty ImagesOn the eve of the Republican National Convention, Food and Drug Administration Commissioner Dr. Stephen Hahn announced that the FDA had issued emergency use authorization for investigational convalescent plasma...